A Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol A
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Paul S Bernstein, MD
University of Utah - John A. Moran Eye Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Lions Eye Institute
Perth, Western Australia, Australia
- Lariboisiere Hospital
Paris, France
- Oxford Eye Hospital, Oxford University Hospitals Nhs Foundation Trust
Oxford, Oxfordshire, United Kingdom
- Moorfields Eye Hospital Nhs Foundation Trust
London, United Kingdom
- Scripps Clinic Medical Group
La Jolla, California, United States
- Jules Stein Eye Institute / David Geffen School of Medicine
Los Angeles, California, United States
- Byers Eye Institute at Stanford University
Palo Alto, California, United States
- Bay Area Retina Associates
Walnut Creek, California, United States
- Retina Consultants of Southern Colorado, P.C.
Colorado Springs, Colorado, United States
- Retina Associates of New Orleans
Metairie, Louisiana, United States
- National Institute of Health, Nih
Bethesda, Maryland, United States
- Cumberland Valley Retina Consultants
Hagerstown, Maryland, United States
- Associated Retinal Consultants, P.C.
Royal Oak, Michigan, United States
- Sierra Eye Associates
Reno, Nevada, United States
- Retina Associates of Cleveland, Inc.
Cleveland, Ohio, United States
- Tulsa Retina Consultants
Tulsa, Oklahoma, United States
- Retina Northwest, Pc
Portland, Oregon, United States
- Southeastern Retina Associates, Pc
Knoxville, Tennessee, United States
- Texas Retina Associates
Dallas, Texas, United States
- University of Utah John A. Moran Eye Center
Salt Lake City, Utah, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 24 Nov 2017
- Primary completion
- 31 Aug 2022
- Completion
- 23 Sept 2022
- Last update posted
- 24 Sept 2024
- Registered enrollment
- 120
- Registry id
- NCT03316300
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.